Competitive intelligence on 
 small-molecule drugs and 
 the 90,000 global patents 
 covering them 

Start your free trial now

DrugPatentWatch Ultimate Plan Preview

Details for Generic Name: nitric oxide

« Back to Dashboard

Summary for Generic Name: nitric oxide

Drug Master File Entries: see list6
Suppliers: see list1

Pharmacology for Ingredient: nitric oxide

Drug ClassVasodilator
Physiological EffectVasodilation

Clinical Trials for: nitric oxide

Nitric Oxide Therapy for Acute Chest Syndrome in Sickle Cell Disease Children
Status: Completed Condition: Acute Chest Syndrome; Sickle Cell Disease

Comparison of Inhaled Nitric Oxide and Oxygen in Patient Reactivity During Acute Pulmonary Vasodilator Testing
Status: Completed Condition: Idiopathic Pulmonary Arterial Hypertension; Congenital Heart Disease With Pulmonary Hypertension; Cardiomyopathy

Use of Inhaled Nitric Oxide to Prevent Pulmonary Hypertension Associated to Stored Blood Transfusion
Status: Not yet recruiting Condition: Hypertension, Pulmonary; Hemolysis

RATNO, Reducing Antibiotic Tolerance Using Nitric Oxide in CF - a Phase 2 Pilot Study
Status: Completed Condition: Cystic Fibrosis

Effect of Nitric Oxide (NO) on Ischemic/Reperfusion Injury During Extended Donor Criteria (EDC) Liver Transplantation
Status: Recruiting Condition: Liver Transplantation; Ischemia/Reperfusion Injury; Oxidative Injury

The Effects of Nitric Oxide for Inhalation During Left Ventricular Assists Device (LVAD) Implantation
Status: Completed Condition: Congestive Heart Failure

Inhaled Nitric Oxide to Prevent and Treat Bronchopulmonary Dysplasia
Status: Completed Condition: Pulmonary Disease

Phase II Evaluation of Exhaled Nitric Oxide (NO)
Status: Completed Condition: Lung Cancer

Exhaled Nitric Oxide and Nasal Lavage Fluid
Status: Completed Condition: Asthma

Inhaled Nitric Oxide by Oxygen Hood in Neonates
Status: Completed Condition: Respiratory Failure; Infant; Persistent Fetal Circulation

Courtesy of
See more clinical trials for this drug
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
nitric oxide
GAS;INHALATION020845Dec 23, 1999RXNo8,573,210*PED<disabled>Y<disabled>
nitric oxide
GAS;INHALATION020845Dec 23, 1999RXNo5,558,083*PED<disabled>Y<disabled>
nitric oxide
GAS;INHALATION020845Dec 23, 1999RXYes8,282,966*PED<disabled>Y<disabled>
nitric oxide
GAS;INHALATION020845Dec 23, 1999RXYes8,291,904*PED<disabled>Y<disabled>
nitric oxide
GAS;INHALATION020845Dec 23, 1999RXNo8,846,112*PED<disabled>Y<disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013   2014  

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2015 thinkBiotech LLC
ISSN: 2162-2639

Preferred citation:

Friedman, Y. Location of pharmaceutical innovation: 2000–2009 Nature Reviews Drug Discovery 9, 835–836 (2010).

Connect with Social Media:

Follow DrugPatentWatch on Twitter
Connect with DrugPatentWatch on Linkedin
Drug Patents on LinkedIn